Oncodesign, Covalab, CheMatech and ABX-CRO launch DRIVE™-MRT
A premium complete, integrated service offer for radiopharmaceuticals drug discovery and generation
Oncodesign
- Service
- Biotech
- Artificial intelligence
- Innovation technologies
- Homing program
- About us
- Contact us
Search
Drug Discovery Service
Integrated or stand alone Drug Discovery services (from hit findings to IND), to discover and evaluate the therapies of tomorrow together.
Participate in research and development programs
Value creation through innovative technologies & R&D partnerships
Fibrosis: Oncodesign and TiumBio sign collaboration agreement for R&D of drug candidates
Under this agreement, Oncodesign will be responsible for identification, chemical synthesis and optimization of Nanocyclix® drug candidates and their early-stage analysis, while TiumBio will be responsible for the advanced evaluation of fibrotic efficacy of the drug candidates. This initial phase of the collaboration will be funded by TiumBio.
Artificial intelligence for therapeutic innovation
For Oncodesign, artificial intelligence (AI) is a powerful tool for accelerating and making drug development more reliable.
Data use for Drug Discovery: InterSystems and Oncodesign Join Forces
Optimization of data use to enhance and accelerate Drug Discovery processes in oncology
Our innovation technologies, a continuum from the molecule to the patient
For more than 25 years, Oncodesign has been investing in precision medicine innovation technologies, which are essential from the very first stages of the Drug Discovery process.
Oncodesign, experts in precision medicine
Oncodesign’s mission is to discover new innovative therapies that are effective against cancers and serious diseases with no known treatments.